Industry Issues Guidelines To Head Off Potential CDS Software Regs

The US Congress and FDA have established that the agency will only oversee high-risk clinical decision-support (CDS) software, but a key CDS industry groups says too much ambiguity remains. The Clinical Decision Support Coalition has published guidelines in a bid to allow industry to self-regulate as much as possible.

More from Digital Technologies

More from Medtech Insight